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Objectives: Circadian blood pressure (BP) pattern is diverse in patients with essential
hypertension. In this study, the relationship between circadian BP pattern and
coronary artery disease (CAD) in hypertensive patients was investigated.
Methods: A total of 716 hypertensive patients (390 men, 326 women) from 2012 to
2013 were included in the study. All other hypertensive patients were excluded if (1)
<18 or >90 years old; (2) pregnant women; (3) under antihypertensive treatment; (4)
BP measurements over 160/100 mmHg; (5) night-work employment; (6) suffering
acute stroke or myocardial infarction within the past 6 months; (7) with sleep apnea
syndrome; (8) evidence of disease or conditions responsible for secondary hyper-
tension; (9) could not tolerate the ambulatory blood pressure monitoring (ABPM);
(10) history of any arrhythmia, congestive heart failure, hepatic failure, kidney failure
and signiﬁcant systemic disease. Circadian BP patterns were evaluated with the 24
hours ABPM and divided into dipper (10-20% SBP fall), non-dipper (0-10% SBP
fall), extreme-dipper (>20% SBP fall) and reverse dipper (SBP nocturnal rise)
according to the nocturnal reduction of systolic blood pressure (SBP). We made the
diagnosis of CAD based on syndrome, electrocardiogram, blood tests (cardiac
markers) and cardiac stress testing or coronary angiogram. Descriptive results are
presented as percentages for discrete variables and as means (standard deviation) for
continuous variables. Multivariate logistic regression analyses were used to study the
relationship between the incidence of CAD and the circadian patterns of BP.
Results: In our study, the BP of 171 patients (23.8%) showed a reverse dipper pattern,
while 370 patients (51.5%) had a non-dipper pattern and 177 patients (24.7%) had a
dipper pattern. Patients with reverse dipper pattern were older (P<0.01), more often
smokers (P<0.01) and had a remarkably higher fasting glucose (P<0.01). Impor-
tantly, the percentage of CAD (P<0.01) and diabetes (P<0.05) were higher among the
patients with reverse dipper pattern. After multivariate logistic regression analysis,
reverse dipper pattern of BP was an independent factor for the incidence of CAD (OR
1.427; 95% CI 1.360-1.498; P<0.01). The result of our study also suggested that 24h-
SBP (OR 1.012; 95% CI 1.011-1.014; P<0.01) and 24h-DBP (OR 1.053; 95% CI
1.050-1.055; P<0.01) were closely related to CAD. Furthermore, age (OR 1.041; 95%
CI 1.027-1.056; P<0.01), diabetes (OR 1.630; 95% CI 1.123-2.366; P<0.05), tri-
glycerides (OR 1.258; 95% CI 1.056-1.499; P<0.05) were independently associated
with a reversed dipper BP pattern.
Conclusions: Reverse dipper pattern of BP examined with the 24h ABPM is an
independent predictor for CAD. The BP of hypertensive patients with CAD and
diabetes were more frequently found to be reverse dipper pattern.
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Objectives: To evaluate the expression of soluble vascular endothelial growth factor
receptor 2 (sVEGFR2) in plasma of hypertensive and hypertensive diabetic patients.
Methods: In this cross-sectional study, eighty-eight cases were enrolled, which were
divided into hypertensive group (n¼31), hypertensive diabetic group (n¼31) and
control group (n¼26). Blood pressure (BP) was obtained from each participant with
mercury sphygmomanometer. The expressions of sVEGFR2 and superoxide dis-
mutase (SOD) were measured by ELISA. Serum lipid proﬁle, glucose and glycosy-
lated hemoglobin A1C (GHbA1c) levels were detected.
Results: The levels of total cholesterol (TC) and body mass index (BMI) were
signiﬁcantly higher in the hypertensive group than those in control group (P<0.05).
The levels of TC, triglyceride (TG), low density lipoprotein cholesterol (LDL-C),
BMI, waist circumference were signiﬁcantly higher in the hypertensive diabetic group
than those in control group (P<0.05). The mean plasma levels of sVEGFR2 and SOD
in both hypertensive diabetic group and hypertensive group were signiﬁcantly
decreased compared to that in the normal group (P<0.05). While the mean plasma
levels of sVEGFR2 and SOD in hypertensive diabetic group were signiﬁcantly
decreased compared to the hypertensive group (P<0.05). There was a signiﬁcantly
positive correlation between sVEGFR2 and SOD in the whole study population
(r¼ 0.224, P¼ 0.0036).
Conclusions: Soluble VEGFR2 expression is decreased in both hypertensive and
hypertensive diabetic patients, and more decreased in hypertensive diabetic patients.
This study indicates that decreased SOD expression may contribute to the reduction of
sVEGFR2. Angiogenesis in these patients is impaired. So sVEGFR2 in plasma mayC176 JACC Vol 64/16/Suppl C j October 16–1be used as a biomarker to assess angiogenesis impairment in patients with hyper-
tension and diabetes.
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Objectives: (1) To investigate the ambulatory blood pressure (ABP) characteristics of
patients who have chronic kidney disease (CKD) complicated with hypertension.(2)
To compare the difference of blood pressure control rate between ABP and ofﬁce
blood pressure (OBP).
Methods: We selected 225 CKD patients complicated with hypertension and 107
essential hypertensives with normal renal function in our hospital during 2012.5-
2013.2. The general information and blood pressure information about these patients
were recorded. Statistically analyzing the ABP characteristics, ABP and OBP control
rate. Analyzing the “White-coat” effect and Pseudo-blood pressure control rate.
Results: (1) Compared with normal renal function hypertensives, the 24h SBP,
nocturnal BP, 24hBP load, diurnal BP load and nocturnal BP load in CKD patients are
signiﬁcantly higher (P<0.05), the anti-dipper BP rate (32.1% vs 5.6%, P<0.05) and
dipper BP rate (15.6% vs 34.6%, P<0.05) in CKD 5 patients are signiﬁcantly
different. There are negative correlation between 24h BP, diurnal BP, nocturnal BP,
BP load and eGFR (P<0.001). (2) Compared with normal renal function hyperten-
sives, the ABP control rate (13.7% vs 28.9%, P<0.05), nocturnal BP control rate
(13.7% vs 59.8%, P<0.05) and nocturnal SBP control rate (15.8% vs 66.8%, P<0.05)
are lower in CKD patients. (3) The ABP control rate is higher than OBP rate in
hypertensives with CKD1-2, and the ABP control rate is lower than OBP control rate
in hypertensives with CKD5 reversely.
Conclusions: (1) The nocturnal blood pressure control rate, which is signiﬁcantly
lower in CKD patients complicated with hypertension, should be attached more
attention. (2) CKD patients complicated with hypertension have a higher incidence of
Pseudo-blood pressure control rate. The OBP is not a good method to judge the blood
pressure control.
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Objectives: (1) To investigate the drug-drug interaction between tacrolimus
and amlodipine in post transplantation hypertension (PTH) patients. (2) To build a
population pharmacokinetics (PPK) model of tacrolimus in PTH patients.
Methods: (1) Prospective research on inﬂuence of amlodipine on tacrolimus phar-
macokinetics was developed in 23 PTH patients hospitalized during April 2012 and
January 2013. At 3 days after tacrolimus administration, and 7 days after amlodipine
administration, collect 2 ml anticoagulant peripheral vein blood at just predose and
0.5, 1, 2, 8, 12 h after dose. Detect the whole blood concentration of tacrolimus using
microparticle enzyme immunoassay analysis method. Patients with uncontrolled
hypertension before amlodipine administration can give antihypertensive agents
expect CCB to control blood pressure. Analysis the gene polymorphism by poly-
merase chain reactionrestriction polymorphism length fragment method, divide
patients into extensive metabolism (EM) and poor metabolism (PM) groups. Compare
the tacrolimus steady-state concentration/dose (C/D), area uder concentration-time
curve (AUC) and blood pressure of PTH patients before and after amlodipine
co-administration. (2) Collect 48 PTH patients using tacrolimus prospectively, sam-
pling method was same with the previous part. Collect demographics data, medication
data and blood concentration data of tacrolimus, etc. PPK analysis is conducted by
using NONMEM. Fit the data with one-compartment model and two-compartment
model respectively. Choose the best one as base model. Build full model with
stepwise regression method, then exclude the covariates which is not signiﬁcant, and
obtain the ﬁnal model. Conduct internal invalidation on ﬁnal model by using
Bootstrap method.
Results: (1) In 23 PTH patients, there were 13 male, 10 female. The mean age was
37.38.8 years. After combined with amlodipine for over 1 week, tacrolimus steady-
state C/D of PTH patients at 0 h, 2 h, 8 h, 12 h and AUC0-12h were elevated signif-
icantly (P<0.05). Systolic blood pressure and diastolic blood pressure were lowered
by 17.8 and 6.1 mmHg respectively. Tacrolimus AUC0-12h of CYP3A4 EM and PM
patients after amlodipine combined were increased by 1.2 and 1.1 times respectively
(P<0.05); Tacrolimus AUC0-12h of CYP3A5 EM and PM patients after amlodipine
combined were increased by 0.7 and 1.2 times respectively (P<0.05). (2) 48 PTH
patients (33 male, 15 female, mean age 35.08.9 years) with 552 samples were
included into the PPK analysis. A two-compartment model with ﬁrst-order absorption
and elimination was chosed as base model, model parameters included apparent
clearance, distribution volume of central compartment, distribution volume of pe-
ripheral compartment, clearance between compartments and absorption rate. CYP3A5
and hematocrit (HCT) was included into the ﬁnal model of clearance, amlodipine was9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
included into the ﬁnal model of clearance rate between compartments. After invali-
dation, the parameter estimates of ﬁnal model were close to the parameter mean of
Bootstrap, and included in the 95% conﬁdence interval.
Conclusions: (1) Amlodipine can increased tacrolimus steady-state C/D and AUC0-12 h
of PTH patients signiﬁcantly. (2) CYP3A5*3 gene polymorphism and hematocrit are
key inﬂuence factors of tacrolimus clearance. Amlodipine is key inﬂuence factor of
tacrolimus clearance rate between compartments.
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Objectives: Left ventricular hypertrophy (LVH) is the most common target organ
damage in hypertension. However, the association of LVH and circadian rhythm of
blood pressure (BP) is unknown. The objective of the present study was to explore the
relationship between circadian rhythm of BP and LVH using ambulatory blood
pressure monitoring (ABPM).
Methods: A total of 325 untreated hypertensive patients were recruited. The patients
were divided into two groups: hypertensive patients with LVH (n¼121) and without
LVH (n¼204). Twenty-four-hour ABPM was performed in all the patients to collect
the following parameters: 24-hour average systolic and diastolic pressure, daytime
average systolic and diastolic pressure, nocturnal average systolic and diastolic
pressure, and night to day BP ratio. The relationship between LVH and the various
ABPM parameters was analyzed.
Results: We found that the average nocturnal systolic blood pressure (SBP) in
hypertensive patients with LVH was higher than that in hypertensive patients without
LVH (14516.1 mmHg vs 13612. 7mmHg, P<0.05). The average night to day SBP
ratio in hypertensive patients with LVH was also higher than that in hypertensive
patients without LVH (0.930.04 vs 0.860.04, P<0.05). Multiple regression anal-
ysis indicate that the average nocturnal SBP and the night to day SBP ratio were
associated with LVH (Odds ratio (OR) 1.67, 95% CI 1.31-3.21; OR: 1.88, 95% CI
1.56-3.78) by adjustment for traditional covariates.
Conclusions: The average nocturnal SBP and the average night-day SBP ratio are
independent risk factors of LVH in patients with hypertension.
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Objectives: Catheter-based renal sympathetic denervation (RDN) was introduced as a
novel interventional technique in recent years, which could simultaneously block the
renal artery afferent and efferent nerve ﬁbers and showed remarkable therapeutic
effects in the treatment of resistant hypertension. In our study, we attempted to use the
QCA system to evaluate the changing about diameter of renal artery after the RDN
immediately.
Methods: 16 patients with resistant hypertension were enrolled and all of them were
accepted the RDN. We used the QCA system to evaluate the diameter of renal artery
before and after the RDN immediately (the renal artery diameter about 2-3 mm were
selected in each patient for measurement).
Results: All of the 16 patients were successfully completed the RDN. No stenosis was
observed in all renal arteries. The result showed that dilation of all patients’ renal
arteries could be observed, and compared with the diameter before RDN, there was
signiﬁcant difference (2.50.4 mm vs 3.10.5 mm, P<0.001, the changing rate
was 24%).
Conclusions: The renal sympathetic denervation could induce the dilation of renal
artery diameter immediately.
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Objectives: To investigate the association between plasma aldosterone (ALD) witn
KCNJ5 (rs2604204) gene polymorphisms in primary hypertension patients.
Methods: 229 new diagnosed primary hypertensive patients without any antihyper-
tensive agents had been selected from October 2011 to January 2014 in the hyper-
tension laboratory of Fujian provincial cardiovascular disease institute. Hypertension
patients were divided into two groups depended on the median of ALD (183.18 ng/l):
high ALD group (n¼114) and control group (n¼115). Clinical data, serum
biochemical, rennin-angiotensin-aldosterone, cortisol, ambulatory blood pressure and
echocardiography data were recorded. Polymerase chain reaction (PCR) was used to
characterize KCNJ5 (rs2604204) genotypes (A/C).JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CResults: (1) The frequency of different genotypes of KCNJ5 (rs2604204) were in
accordance with Hardy-Weinberg equilibrium in our study (P>0.05). (2) Clinical
characteristics:Compared with control group, the triglyceride (TG), uric acid (UA),
insulin, insulin resistance index, renin, angiotensin I, angiotensin II, cortisol, 24hSBP,
dSBP, SD (PD), SD (PS), left ventricular mass index (LVMI) were high in high ALD
group (P<0.05). The gender, age, height, weight, BMI, waist circumference, total
cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipopro-
tein cholesterol (HDL-C), fasting blood glucose (FBG), glycosylated hemoglobin A1c
(HbA1c), sodium, potassium, 24h DBP, dDBP, nSBP, nDBP showed no signiﬁcant
difference between two groups. (3) Gene polymorphisms: Compared with control
group, the distribution frequency of AC and CC genotypes of KCNJ5 gene were more
in high ALD group (x2¼10.93,P¼0.004),and C allelic frequency was also more in
high ALD group (x2¼9.78, P¼0.002). There was no signiﬁcant difference between
AC and CC genotypes of two groups. Compared with hypertensive patients with AA
genotype, patients with C allelic showed increased high ALD risk (x2¼9.808,
OR¼2.36 95% CI 1.380-4.049, P¼0.002). (4) Analysis of the risk factors of high
ALD: After adjusting the TG, UA, cortisol, insulin, insulin resistance index, renin,
angiotensin I, angiotensin II, cortisol, 24h SBP, dSBP, SD (PD), SD (PS), LVMI,
logistic regression analysis showed that KCNJ5 genotype, angiotensin II, cortisol,
dSBP entered into the regression equation, compared with hypertensive patients with
AA genotype, hypertensive patients with C allelic showed increased high ALD risk
(OR¼2.33, 95% CI 1.255-4.353, P¼0.007).
Conclusions: The KCNJ5 (rs2604204) gene C allelic might be a susceptibility factor
to the high ALD in primary hypertensive patients. Angiotensin II, cortisol, dSBP are
related to the high ALD in primary hypertensive patients.
The natural science foundation of Fujian Province (No: 2014Y01010261)
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Objectives: To evaluate the curative effect of Bushen Hemai Prescription combined
with antihypertensive chemical medicine on the control rate of systolic blood pressure
(SBP), pulse pressure (PP) and left ventricular hypertrophy (LVH) in senile isolated
systolic hypertension (ISH) patients.
Methods: It was designed as multi-center clinical research (5 medical centers) of
completely randomized, single blind and parallel blank control. After 2 weeks of
introduction period, 286 cases of aged over 60 years, with more than 15-20 years
duration and PP 60 mmHg (8 kPa) were enrolled and were divided into the control
group (n¼144) and the experimental group (n¼142). During the observation period of
24 weeks, patients were allocated with chemical medicine (Amlodipine + Indapamide)
and combination therapeutic regimen (Bushen Hemai Prescription combined with
Amlodipine + Indapamide). 24 h ambulatory blood pressure parameters were monitored
according to the British Oxford Medliog ambulatory blood pressure analysis system.
Left ventricular end diastolic diameter (LVEDd), interventricular septal thickness
(IVSTDd) and left ventricular posterior wall thickness (PWTDd) of 3-5 continuous
heartbeat cycle were determined by GEVivid 7 PRO color Doppler ultrasound diag-
nostic instrument. Left ventricular mass (LVM), left ventricular mass index (LVMI) and
relative wall thickness (RWT) were calculated according to the Devercux formula.
Results: After therapy, analysis of the control rate of SBP and PP was 45.14%
(control group) and 74.32% (experimental group) by chi square test of FAS analysis,
P<0.01, and 48% (control group) and 74.96% (experimental group) by chi square test
of PPS analysis, P<0.01. The efﬁciency analysis of circadian rhythms was 25.93%
(control group) and 47.06% (experimental group) by chi square test of FAS analysis,
P<0.01, and 25% (control group) and 46.39% (experimental group) by chi square test
of PPS analysis, P<0.01. Ultrasonic Beckoning graph showed that data about LVH
were decreased in both two groups after treatment. LVM and LVMI were decreased
signiﬁcantly in experimental group than in control group (P<0.01), suggesting cardiac
diastolic function was improved more signiﬁcantly. There is no central difference of
each data among the 5 medical centers by Breslow-Day test, P>0.05.
In the process of study, the incidence of adverse events was 2.08% (A group) and
0% (B group), demonstrating no statistically signiﬁcance difference between groups
by corrected chi square test, P>0.05. And none was serious adverse event.
Conclusions: Combination therapeutic regimen (Bushen Hemai Prescription com-
bined with Amlodipine + Indapamide) could more effectively control 24h blood
pressure, improve the control rate of systolic blood pressure (SBP), pulse pressure
(PP) and improve left ventricular diastolic function, reverse concentric LVH in senile
isolated systolic hypertension (ISH) patients. This combination therapeutic regimen
may bring a greater long-term beneﬁt to senile ISH patients.
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and Meta-Analysis
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Objectives: Renal denervation (RDN) emerges as a potential adjunct in the treatment
of resistant hypertension (RH) with limited data. We aim to evaluate the efﬁcacy of
RDN mainly by ambulatory blood pressure monitoring (ABPM).ardiovascular Disease Clinical Research C177
